Clinical Trial Update: Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline [NA]

View source ↗

Summary

This clinical trial update reports that the IPROACTIF program evaluating preservation of functioning and prevention of cognitive decline has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Hypertensive Heart Disease
• Ischemic Heart Disease

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease), Uncontrolled Diabetes (HBA1c ≥ 10) | NA | Status: COMPLETED | Results posted: 2025-08-19